Citigroup Inc Immunity Bio, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Citigroup Inc holds 109,870 shares of IBRX stock, worth $493,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares

109,870

Previous 108,986 0.81%

Holding current value

$493,316

Previous $688,000 40.84%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.32 - $6.7 $2,934 - $5,922	884 Added 0.81%	109,870 $407,000
Q2 2024 Aug 12, 2024	SELL	$4.82 - $9.15 $4.91 Million - $9.33 Million	-1,019,460 Reduced 90.34%	108,986 $688,000
Q1 2024 May 10, 2024	BUY	$3.23 - $6.17 $2.64 Million - $5.04 Million	816,424 Added 261.66%	1,128,446 $6.06 Million
Q4 2023 Feb 09, 2024	BUY	$1.25 - $5.21 $382,487 - $1.59 Million	305,990 Added 5072.78%	312,022 $1.57 Million
Q3 2023 Nov 09, 2023	SELL	$1.29 - $3.1 $48,351 - $116,194	-37,482 Reduced 86.14%	6,032 $10,000
Q2 2023 Aug 10, 2023	BUY	$1.53 - $6.41 $54,747 - $229,369	35,783 Added 462.85%	43,514 $120,000
Q1 2023 May 11, 2023	SELL	$1.35 - $4.78 $276,579 - $979,297	-204,874 Reduced 96.36%	7,731 $14,000
Q4 2022 Feb 09, 2023	SELL	$4.35 - $6.77 $700,519 - $1.09 Million	-161,039 Reduced 43.1%	212,605 $1.08 Million
Q3 2022 Nov 10, 2022	BUY	$3.65 - $6.43 $1.31 Million - $2.31 Million	358,916 Added 2436.96%	373,644 $1.86 Million
Q2 2022 Aug 10, 2022	SELL	$2.68 - $6.14 $210,229 - $481,646	-78,444 Reduced 84.19%	14,728 $55,000
Q1 2022 May 12, 2022	SELL	$5.05 - $7.53 $1.47 Million - $2.19 Million	-290,323 Reduced 75.7%	93,172 $523,000
Q4 2021 Feb 10, 2022	BUY	$5.67 - $10.18 $1.13 Million - $2.03 Million	199,019 Added 107.88%	383,495 $2.33 Million
Q3 2021 Nov 10, 2021	BUY	$9.17 - $14.24 $1.69 Million - $2.63 Million	184,476 New	184,476 $1.8 Million

Others Institutions Holding IBRX

# of Institutions

202

Shares Held

70M

Call Options Held

1.68M

Put Options Held

1.31M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account